Search Results for 'Taf Insti'

Taf Insti published presentations and documents on DocSlides.

L’équipe de rédaction

L’équipe de rédaction

gelbero
235 Slides

François Raffi. CHU Nantes. Gilles Peytavin. CHU ...

IAS – USA Fall New York Course: Case Discussion

IAS – USA Fall New York Course: Case Discussion

jalin
61 Slides

Luke . Jerram. Disclosures: Educational grant supp...

CONFERENCE ON RETROVIRUSES

CONFERENCE ON RETROVIRUSES

winnie
41 Slides

AND OPPORTUNISTIC INFECTIONS. CROI 2023. 19-23 FEB...

GS-US-380-1878 GS-US-380-1844

GS-US-380-1878 GS-US-380-1844

phoebe
8 Slides

GS-US-380-1961. . Switch to BIC/FTC/TAF. Design...

Webinar presented by : ANDES

Webinar presented by : ANDES

teresa
29 Slides

Prediction. . of . events. . after. ART. initia...

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

deena
32 Slides

Pedro Cahn. Disclosures. Advisory. . boards. : Me...

Stephanie Cox Gilead Sciences

Stephanie Cox Gilead Sciences

emery
6 Slides

Foster City, CA. ULTRASENSITIVE HIV-1 DRUG RESISTA...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

scarlett
28 Slides

Judith S. Currier, MD, MSc. Professor of Medicine....

When and What To Start Melanie A. Thompson, MD

When and What To Start Melanie A. Thompson, MD

paxton651
14 Slides

Thacker & Thompson, MD. Atlanta, Georgia. Fina...

Safety of Tenofovir

Safety of Tenofovir

deandre922
23 Slides

Alafenamide. in Renal Impairment. A Pozniak. 1. ,...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

micah
16 Slides

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

Copyright © 2024 DocSlides. All Rights Reserved